Have your own idea? Try our Stock Screener
Pakistani (KSE) Pharma Industry Analysis
UpdatedJul 06, 2026
DataAggregated Company Financials
Companies11
- 7D4.0%
- 3M17.1%
- 1Y2.2%
- YTD-6.3%
In the last week, the Pharma industry is up 4.0%, with GlaxoSmithKline Pakistan up 5.5%. Despite this gain, the industry's performance has been flat over the past year. As for the next few years, earnings are expected to grow by 11% per annum.
Industry Valuation and Performance
Has the Pakistani Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 06 Jul 2026 | PK₨492.3b | PK₨316.6b | PK₨34.3b | 14.8x | 14.4x | 1.6x |
| Wed, 03 Jun 2026 | PK₨449.2b | PK₨316.6b | PK₨34.3b | 13.3x | 13.1x | 1.4x |
| Fri, 01 May 2026 | PK₨435.5b | PK₨312.0b | PK₨33.3b | 13.1x | 13.1x | 1.4x |
| Sun, 29 Mar 2026 | PK₨425.8b | PK₨306.1b | PK₨31.5b | 13.7x | 13.5x | 1.4x |
| Tue, 24 Feb 2026 | PK₨500.9b | PK₨298.2b | PK₨29.4b | 16.7x | 17x | 1.7x |
| Thu, 22 Jan 2026 | PK₨551.7b | PK₨297.3b | PK₨29.2b | 17.3x | 18.9x | 1.9x |
| Sat, 20 Dec 2025 | PK₨498.4b | PK₨297.4b | PK₨29.4b | 15.7x | 17x | 1.7x |
| Mon, 17 Nov 2025 | PK₨504.6b | PK₨297.4b | PK₨29.4b | 16.1x | 17.2x | 1.7x |
| Wed, 15 Oct 2025 | PK₨536.0b | PK₨286.9b | PK₨28.0b | 23x | 19.1x | 1.9x |
| Fri, 12 Sep 2025 | PK₨525.2b | PK₨285.7b | PK₨29.0b | 23.7x | 18.1x | 1.8x |
| Sun, 10 Aug 2025 | PK₨508.6b | PK₨279.5b | PK₨26.2b | 23.2x | 19.4x | 1.8x |
| Tue, 08 Jul 2025 | PK₨498.0b | PK₨279.5b | PK₨26.2b | 22.7x | 19x | 1.8x |
| Thu, 05 Jun 2025 | PK₨449.2b | PK₨279.5b | PK₨26.2b | 20.6x | 17.1x | 1.6x |
| Sat, 03 May 2025 | PK₨435.8b | PK₨274.2b | PK₨23.3b | 18.8x | 18.7x | 1.6x |
| Mon, 31 Mar 2025 | PK₨483.2b | PK₨271.0b | PK₨22.9b | 20.6x | 21.1x | 1.8x |
| Wed, 26 Feb 2025 | PK₨474.6b | PK₨257.3b | PK₨19.3b | 24.3x | 24.6x | 1.8x |
| Fri, 24 Jan 2025 | PK₨503.9b | PK₨257.1b | PK₨19.2b | 23.9x | 26.3x | 2x |
| Sun, 22 Dec 2024 | PK₨460.3b | PK₨257.0b | PK₨19.0b | 22.2x | 24.2x | 1.8x |
| Tue, 19 Nov 2024 | PK₨388.1b | PK₨257.0b | PK₨19.0b | 19.7x | 20.4x | 1.5x |
| Thu, 17 Oct 2024 | PK₨298.1b | PK₨244.3b | PK₨15.2b | 18.4x | 19.6x | 1.2x |
| Sat, 14 Sep 2024 | PK₨266.0b | PK₨251.2b | PK₨12.3b | 15.8x | 21.6x | 1.1x |
| Mon, 12 Aug 2024 | PK₨243.1b | PK₨243.6b | PK₨8.3b | 17.8x | 29.4x | 1x |
| Wed, 10 Jul 2024 | PK₨253.7b | PK₨243.6b | PK₨8.3b | 16.5x | 30.7x | 1x |
| Fri, 07 Jun 2024 | PK₨216.4b | PK₨238.7b | PK₨8.0b | 15.3x | 26.9x | 0.9x |
| Sun, 05 May 2024 | PK₨189.7b | PK₨234.6b | PK₨9.0b | 24.2x | 21x | 0.8x |
| Tue, 02 Apr 2024 | PK₨170.1b | PK₨226.1b | PK₨6.9b | 22.5x | 24.5x | 0.8x |
| Thu, 29 Feb 2024 | PK₨172.1b | PK₨221.2b | PK₨6.3b | 21.2x | 27.4x | 0.8x |
| Sat, 27 Jan 2024 | PK₨161.6b | PK₨221.2b | PK₨6.3b | 19.6x | 25.7x | 0.7x |
| Mon, 25 Dec 2023 | PK₨163.4b | PK₨221.2b | PK₨6.3b | 20.4x | 26x | 0.7x |
| Wed, 22 Nov 2023 | PK₨160.5b | PK₨218.2b | PK₨6.2b | 21.6x | 25.9x | 0.7x |
| Fri, 20 Oct 2023 | PK₨136.7b | PK₨211.7b | PK₨6.6b | 16.3x | 20.7x | 0.6x |
| Sun, 17 Sep 2023 | PK₨120.7b | PK₨209.3b | PK₨8.2b | 12.6x | 14.7x | 0.6x |
| Tue, 15 Aug 2023 | PK₨139.6b | PK₨205.6b | PK₨8.7b | 12.9x | 16x | 0.7x |
| Thu, 13 Jul 2023 | PK₨143.1b | PK₨205.6b | PK₨8.7b | 13.1x | 16.4x | 0.7x |
Price to Earnings Ratio
16.4x
Current Industry PE
- Investors are pessimistic on the Pakistani Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 14.4x which is lower than its 3-year average PE of 21.0x.
- The 3-year average PS ratio of 1.3x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 58% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare industry?
| PK Market | 2.71% | |
| Healthcare | 3.50% | |
| Pharma | 3.95% | |
| Pharma | 3.95% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | PK₨387.01 | 5.5% +PK₨6.4b | -3.0% | PE11.7x | |
| ABOT Abbott Laboratories (Pakistan) | PK₨1.02k | 5.1% +PK₨4.9b | -1.6% | PE12x | |
| AGP AGP | PK₨217.25 | 6.0% +PK₨3.4b | 14.1% | PE16.3x | |
| HINOON Highnoon Laboratories | PK₨1.05k | 5.7% +PK₨3.0b | 6.2% | PE13.2x | |
| OTSU Otsuka Pakistan | PK₨374.63 | 24.2% +PK₨883.1m | 27.6% | PE13x |